Cancer Incidence and Mortality for All Sites of Cancer, Richmond County (Staten Island), 2009-2013

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males Females Males Females
Average Annual Cases Rate per 100,000 Males 95% CI (+/-) Average Annual Cases Rate per 100,000 Females 95% CI (+/-) Average Annual Deaths Rate per 100,000 Males 95% CI (+/-) Average Annual Deaths Rate per 100,000 Females 95% CI (+/-)
All Invasive Malignant Tumors 1345.0 577.1 14.3 1393.2 487.5 11.7 403.4 186.9 8.4 404.4 137.4 6.1
Oral cavity and pharynx
All Oral cavity and pharynx 34.6 13.9 2.1 15.6 5.3 1.2 7.0 2.9 1.0 4.0 1.4 0.6
Lip 0.4 0.1 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0
Tongue 10.2 4.0 1.1 4.2 1.5 0.7 1.8 0.8 0.5 0.4 0.1 0.2
Salivary gland 2.6 1.2 0.7 2.4 0.7 0.4 0.4 0.2 0.3 0.6 0.2 0.2
Floor of mouth 1.6 0.6 0.5 0.4 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0
Gum & other mouth 4.8 2.3 0.9 3.4 1.2 0.6 0.6 0.2 0.3 0.6 0.2 0.2
Nasopharynx 4.0 1.5 0.7 1.8 0.6 0.4 1.2 0.4 0.4 0.8 0.3 0.3
Tonsil 6.4 2.4 0.8 1.8 0.6 0.4 0.8 0.3 0.3 0.2 0.1 0.1
Oropharynx 2.0 0.9 0.6 0.4 0.1 0.2 0.8 0.4 0.4 0.4 0.1 0.2
Hypopharynx 2.0 0.8 0.5 0.4 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.0
Other buccal cavity and pharynx 0.6 0.2 0.2 0.6 0.2 0.2 1.0 0.5 0.4 1.0 0.4 0.3
Digestive system
All Digestive system 252.2 109.3 6.2 216.6 73.9 4.5 124.2 55.6 4.5 102.2 34.3 3.0
Esophagus 14.0 6.0 1.5 3.8 1.3 0.6 12.0 5.0 1.3 4.0 1.4 0.6
Stomach 24.2 10.7 2.0 16.6 5.8 1.3 11.8 5.5 1.5 7.2 2.3 0.8
Small intestine 6.6 2.8 1.0 4.8 1.6 0.7 0.2 0.1 0.1 0.4 0.1 0.2
Colorectal 119.0 53.3 4.4 120.0 41.0 3.3 41.2 19.7 2.8 42.2 14.2 1.9
Colon excluding rectum 82.6 37.5 3.7 91.4 31.3 2.9 35.4 17.2 2.6 36.0 12.2 1.8
Cecum 13.2 6.2 1.5 23.6 8.1 1.5            
Appendix 1.4 0.6 0.4 4.2 1.5 0.7            
Ascending colon 14.2 6.4 1.5 19.2 6.7 1.4            
Hepatic flexure 3.2 1.6 0.8 3.2 1.1 0.6            
Transverse colon 9.6 4.3 1.2 6.6 2.2 0.8            
Splenic flexure 2.6 1.2 0.7 0.8 0.3 0.3            
Descending colon 6.2 2.7 1.0 4.6 1.6 0.6            
Sigmoid colon 27.2 12.2 2.1 22.6 7.7 1.4            
Large intestine, NOS 5.0 2.3 0.9 6.6 2.1 0.7            
Rectum & rectosigmoid 36.4 15.8 2.4 28.6 9.7 1.6 5.8 2.5 1.0 6.2 2.0 0.7
Rectosigmoid junction 11.4 5.2 1.4 10.6 3.6 1.0            
Rectum 25.0 10.6 1.9 18.0 6.1 1.3            
Anus, anal canal & anorectum 3.0 1.3 0.7 5.4 1.8 0.7 0.8 0.4 0.4 1.2 0.4 0.3
Liver and intrahepatic bile duct 40.8 15.9 2.3 15.4 5.1 1.2 26.2 11.0 1.9 12.0 4.0 1.0
Liver 36.4 14.1 2.1 12.2 4.0 1.0 21.2 8.9 1.7 8.4 2.8 0.9
Intrahepatic bile duct 4.4 1.8 0.8 3.2 1.1 0.5 5.0 2.1 0.8 3.6 1.2 0.6
Gallbladder 1.4 0.6 0.5 4.2 1.5 0.7 2.0 1.0 0.6 1.8 0.6 0.4
Other biliary 4.6 2.0 0.8 3.2 1.2 0.6 0.6 0.3 0.3 1.0 0.3 0.3
Pancreas 35.0 15.0 2.3 37.4 12.7 1.9 29.0 12.5 2.1 31.0 10.5 1.7
Retroperitoneum 1.2 0.5 0.4 1.2 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0
Peritoneum, omentum & mesentery 0.6 0.3 0.3 3.4 1.1 0.5 0.2 0.1 0.2 0.8 0.3 0.3
Other digestive organs 1.8 0.8 0.6 1.2 0.4 0.3 0.2 0.1 0.1 0.6 0.2 0.3
Respiratory system
All Respiratory system 201.4 89.0 5.7 170.4 59.1 4.0 125.2 58.1 4.7 107.6 36.9 3.2
Nasal cavity, middle ear & sinuses 2.4 1.2 0.7 1.0 0.3 0.3 0.4 0.1 0.2 0.2 0.1 0.1
Larynx 18.2 7.4 1.6 5.4 1.8 0.7 4.6 2.1 0.9 1.6 0.5 0.4
Lung and bronchus 180.4 80.3 5.4 163.2 56.5 3.9 119.8 55.6 4.6 105.8 36.3 3.2
Pleura 0.0 0.0 0.0 0.4 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.0
Trachea, mediastinum, other respiratory 0.4 0.2 0.3 0.4 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.0
Soft tissue, bone, and skin
Bones & joints 3.4 1.5 0.7 1.6 0.7 0.5 0.8 0.4 0.4 0.2 0.1 0.1
Soft tissue (including heart) 10.0 4.3 1.2 6.6 2.4 0.9 3.0 1.3 0.7 3.4 1.2 0.6
Skin~ 54.2 23.8 2.9 43.8 15.8 2.1 7.0 3.2 1.1 3.6 1.3 0.6
Melanoma of the skin 49.8 21.7 2.8 40.2 14.5 2.1 5.2 2.3 0.9 2.8 1.0 0.5
Breast
Breast 3.0 1.3 0.6 381.0 131.8 6.0 0.4 0.1 0.2 62.6 21.2 2.4
Female genital system
All Female genital system       171.6 58.6 4.0       49.0 16.3 2.1
Cervix uteri       19.0 7.1 1.4       6.4 2.1 0.7
Corpus uterus and NOS       103.0 34.5 3.0       14.4 4.9 1.2
Ovary       35.2 12.1 1.8       25.4 8.4 1.5
Vagina       2.2 0.7 0.4       1.2 0.4 0.3
Vulva       9.0 3.0 0.9       0.8 0.2 0.2
Other female genital organs       3.2 1.1 0.6       0.8 0.2 0.2
Male genital system
All Male genital system 346.4 140.6 6.8       33.2 18.0 2.8      
Prostate 329.4 132.8 6.6       32.0 17.4 2.7      
Testis 13.4 6.1 1.5       0.6 0.3 0.3      
Penis 2.8 1.3 0.7       0.6 0.3 0.4      
Other male genital organs 0.8 0.3 0.3       0.0 0.0 0.0      
Urinary system
All Urinary system 165.0 72.1 5.1 65.4 22.7 2.5 27.2 12.4 2.2 13.4 4.5 1.1
Urinary bladder (including in situ) 95.8 43.6 4.0 31.6 10.8 1.7 16.4 7.9 1.8 6.6 2.1 0.7
Kidney and renal pelvis 62.6 25.3 2.9 32.0 11.3 1.8 10.4 4.4 1.2 6.4 2.2 0.8
Ureter 2.8 1.5 0.8 1.0 0.4 0.4 0.2 0.1 0.2 0.2 0.1 0.2
Other urinary organs 3.8 1.8 0.8 0.8 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1
Eye & orbit
Eye & orbit 2.8 1.2 0.6 1.6 0.5 0.4 0.2 0.1 0.1 0.0 0.0 0.0
Brain and central nervous system
All Brain / other nervous system (all behaviors) 33.0 14.0 2.2 56.8 20.6 2.5 11.0 4.7 1.3 10.0 3.6 1.0
Malignant brain / other nervous system 17.2 7.5 1.6 15.4 5.9 1.4 9.2 4.0 1.2 8.4 3.1 1.0
Malignant brain 16.0 7.0 1.6 13.6 5.1 1.3            
Malignant other nervous system 1.2 0.5 0.4 1.8 0.8 0.5            
Benign brain / other nervous system* 15.8 6.5 1.5 41.4 14.7 2.0 1.8 0.7 0.4 1.6 0.5 0.4
Benign brain 1.4 0.7 0.5 2.6 1.1 0.6            
Benign other nervous system 14.4 5.8 1.4 38.8 13.5 1.9            
Endocrine system
All Endocrine system 45.8 18.7 2.5 129.6 49.3 3.9 1.2 0.4 0.4 1.6 0.6 0.4
Thyroid 43.2 17.5 2.4 126.6 48.1 3.8 0.8 0.3 0.3 0.6 0.2 0.2
Other endocrine (including thymus) 2.6 1.2 0.6 3.0 1.2 0.6 0.4 0.2 0.2 1.0 0.4 0.3
Lymphomas
All Lymphomas 68.8 30.3 3.3 66.2 23.9 2.6 17.6 8.1 1.8 12.0 4.3 1.1
Hodgkin lymphoma 9.2 3.9 1.1 9.8 4.0 1.1 1.2 0.5 0.4 0.2 0.1 0.1
Non-Hodgkin lymphomas 59.6 26.4 3.1 56.4 19.8 2.4 16.4 7.6 1.7 11.8 4.2 1.1
Myeloma
All Myeloma 26.4 11.6 2.0 19.2 6.5 1.3 5.8 2.6 1.0 5.0 1.7 0.7
Leukemias
All Leukemias 51.8 23.1 2.9 39.0 13.9 2.0 17.6 8.4 1.8 12.6 4.5 1.1
Lymphocytic leukemias 27.8 12.5 2.1 20.4 7.1 1.4 3.6 1.7 0.8 3.2 1.1 0.5
Acute lymphocytic leukemia 4.4 2.0 0.9 4.0 1.7 0.8 0.6 0.3 0.3 0.4 0.1 0.2
Chronic lymphocytic leukemia 20.6 9.2 1.8 16.2 5.3 1.2 2.8 1.4 0.7 2.8 1.0 0.5
Other lymphocytic leukemias 2.8 1.3 0.7 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0
Myeloid and monocytic leukemias 21.8 9.7 1.9 16.4 6.0 1.3 10.0 4.8 1.4 6.0 2.1 0.8
Acute myeloid leukemia 12.8 5.8 1.5 10.6 3.9 1.1 7.6 3.7 1.2 4.8 1.7 0.7
Acute monocytic leukemia 0.6 0.3 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0
Chronic myeloid leukemia 6.8 2.7 0.9 4.6 1.6 0.7 1.0 0.5 0.4 0.4 0.1 0.2
Other myeloid/monocytic leukemias 1.6 0.8 0.6 1.0 0.4 0.4 1.4 0.6 0.5 0.8 0.3 0.3
Other leukemias 2.2 0.9 0.6 2.2 0.7 0.4 4.0 1.9 0.9 3.4 1.3 0.6
Other acute leukemias 0.6 0.3 0.3 1.0 0.3 0.3 1.4 0.6 0.5 1.8 0.6 0.4
Aleukemic, subacute, leukemia NOS 1.6 0.7 0.5 1.2 0.4 0.3 2.6 1.3 0.7 1.6 0.6 0.4
Mesothelioma
Mesothelioma 4.2 2.0 0.9 1.8 0.6 0.4            
Kaposi sarcoma
Kaposi sarcoma 3.6 1.9 0.9 0.8 0.3 0.3            
Myelodysplastic syndromes
Myelodysplastic syndromes 14.6 7.0 1.7 9.6 3.2 0.9            
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^ 14.4 6.2 1.5 13.6 5.0 1.2            
Ill defined and unspecified sites
Ill defined and unspecified sites 25.2 11.9 2.1 23.8 8.0 1.5 23.8 11.2 2.1 18.8 6.1 1.3

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Brain and other nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2015.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.